Peptic Ulcers
6 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Risk Factors Affecting Mortality in Perforated Peptic Ulcer (NCT07050199) | Maharajgunj Medical Campus | 2022-04-01 |
| Oral Versus IV Proton Pump Inhibitor in High-risk Bleeding Peptic Ulcers After Endoscopic Hemostasis (NCT01182597) | National Taiwan University Hospital | 2010-08-01 |
| Comparison of Intravenous Omeprazole to Ranitidine on Recurrent Bleeding After Endoscopic Treatment of Bleeding Ulcer (NCT00247130) | Keio University | 2005-10-01 |
| High Versus Standard Dose of Proton Pump Inhibitors (PPIs) in Peptic Ulcer Bleeding (NCT00374101) | Casa Sollievo della Sofferenza IRCCS | 2005-01-01 |
| Celebrex Low Dose ASA Study Examining the Incidence of Gastroduodenal Ulcers in a Healthy Population (NCT00137033) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2004-09-01 |
| Long-term Pantoprazole Trial in Patients With Symptoms of Chronic Acid Peptic Complaints (BY1023/VMG-708) (NCT00261300) | Takeda | 2000-10-01 |
Track Peptic Ulcers automatically
Every clearance here is in the API, with alerts when new ones post.